While the ε4 allele of the apolipoprotein E (APOE4) gene is a well-known genetic risk factor for the development of sporadic AD, recent GWAS studies have uncovered dozens of other genetic risk factors, opening the doors to studying the potential impact of additive genetic risk for AD on early life. The gene discussed is APOE; the disease is Alzheimer disease.